A Spanish contract development and manufacturing organization (CDMO) has secured investment from Madrid-headquartered Suanfarma S.A. to further its international growth plans. Idifarma, which specializes in high potency development and manufacturing and spray drying to solve low solubility challenges, has grown from a small start-up business established in 2001 to a global CDMO working with more than 100 pharmaceutical companies. As part of a planned process to replace venture-capital fina...